BioAdaptives (BDPT) director receives Series D preferred stock grant as board pay
Rhea-AI Filing Summary
BioAdaptives, Inc. reported that director Mark P. Frissora received 12,500 shares of Series D Convertible Preferred Stock as compensation for board services. Each preferred share is convertible into 100 common shares, for 1,250,000 underlying common shares, subject to a 4.9% beneficial ownership cap. Following this grant, he holds 88,771 Series D preferred shares. The preferred shares carry 100 votes each and generally cannot be converted for six months, except upon liquidation.
Positive
- None.
Negative
- None.
Insights
Director received preferred stock as non-cash board compensation.
Director Mark P. Frissora was issued 12,500 shares of Series D Convertible Preferred Stock as consideration for board services under a Board of Directors Agreement dated February 3, 2025. This is compensation, not an open-market trade.
Each preferred share converts into 100 common shares, implying 1,250,000 common shares, but conversion is limited by a 4.9% beneficial ownership cap and generally deferred for six months. The Series D shares carry 100 votes each, so this grant primarily affects voting power and potential future equity exposure rather than immediate share float.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Series D Convertible Preferred Stock | 12,500 | $0.00 | -- |
Footnotes (1)
- Represents shares of Series D Convertible Preferred Stock issued as compensation for board services pursuant to that certain Board of Directors Agreement, dated February 3, 2025, between the Issuer and the Reporting Person. The Reporting Person's shares of Series D Convertible Preferred Stock, par value $0.0001 per share, are convertible into shares of common stock, par value $0.0001 per share, at a ratio of 100 shares of common stock for each share of Series D Convertible Preferred Stock, subject to a 4.9% beneficial ownership limitation. No shares of Series D Convertible Preferred Stock may be converted until six months after the date of issuance, except in the case of liquidation, whereupon the conversion will occur immediately. Each share of Series D Convertible Preferred Stock outstanding at the time of a meeting of stockholders or a solicitation of consent is entitled to 100 votes on matters of the Issuer, without regard to the beneficial ownership limitation. The right to convert does not expire.